Intranasal Sufentanil versus Intravenous Morphine Sulfate in Pain Management of Patients with Extremity Trauma
Journal of Practical Emergency Medicine,
Vol. 2 No. 3 (2015),
29 July 2015
,
Page 116-121
https://doi.org/10.22037/ijem.v2i3.9247
Abstract
Introduction: Pain is one of the most common complaints of patients referred to emergency department (ED) and its control is one of the most important responsibilities of the physicians. The present study was designed, aiming to compare the efficiency of intranasal sufentanil and intravenous (IV) morphine sulfate in controlling extremity trauma patients' pain in ED. Methods: In the present clinical trial, extremity trauma cases referred to the ED of Imam Hossein Hospital, Tehran, Iran, from October 2014 to March 2015 were randomly divided into 2 groups treated with intranasal sufentanil (0.3 µg/kg) and IV morphine sulfate (0.1 mg/kg) single-doses. Demographic data and information regarding the quality of pain control such as pain severity before intervention and 15, 30, and 60 minutes after intervention, and probable side effects were gathered using a checklist and compared between the 2 groups. Results: 88 patients with the mean age of 35.5 ± 14.8 years were included in the study (81.8% male). 44 patients received IV morphine sulfate and 44 got intranasal sufentanil. No significant difference was detected between the 2 groups regarding baseline characteristics. In addition, there was no significant difference in the groups regarding pain relief at different studied times (p = 0.12; F = 2.46; df: 1, 86). Success rate of the drugs also did not differ significantly at different studied times (p = 0.52). No significant difference was seen between the groups regarding side effects (p = 0.24). Conclusion: Based on the results of this study, it seems that intranasal sufentanil has a similar effect to IV morphine sulfate in rapid, efficient, and non-invasive pain control in patients with traumatic extremity injuries.- سوفنتانیل اینترانازال؛ مورفین؛ تروما؛ بخش اورژانس؛ کنترل درد
How to Cite
References
Warfield CA, Kahn CH. Acute pain management. Programs in US hospitals and experiences and attitudes among US adults. Anesthesiology. 1995;83(5):1090-4.
Maciejewski D. Sufentanil in anaesthesiology and intensive therapy. Anaesthesiol Intensive Ther. 2012;44(1):35-41.
Scholz J, Steinfath M, Schulz M. Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. Clin Pharmacokinet. 1996;31(4):275-92.
Alimohammadi H, Baratloo A, Abdalvand A, Rouhipour A, Safari S. Effects of Pain Relief on Arterial Blood O2 Saturation. Trauma mon. 2014;19(1):e14034.
Baratloo A, Negida A, El Ashal G, Behnaz N. Intravenous Caffeine for the Treatment of Acute Migraine: A Pilot Study. J Caffeine Res. 2015:[In press].
Hosseini M, Karami Z, Janzadenh A, et al. The effect of intrathecal administration of muscimol on modulation of neuropathic pain symptoms resulting from spinal cord injury; an experimental study. Emergency. 2014;2(4):151-7.
Hosseini M, Yousefifard M, Aziznejad H, Nasirinezhad F. The Effect of bone marrow derived mesenchymal stem cell transplantation on allodynia and hyperalgesia in neuropathic animals: A systematic review with meta-analysis. Biol Blood Marrow Transplant. 2015:[In press].
Alimohammadi H, Azizi M-R, Safari S, Amini A, Kariman H, Hatamabadi HR. Axillary Nerve Block in Comparison with Intravenous Midazolam/Fentanyl for Painless Reduction of Upper Extremity Fractures. Acta Med Iran. 2014;52(2):122-4.
Vadivelu N, Mitra S, Narayan D. Recent advances in postoperative pain management. Yale J Biol Med. 2010;83(1):11-25.
Roelofse J, Shipton E, De La Harpe C, Blignaut R. Intranasal sufentanil/midazolam versus ketamine/midazolam for analgesia/sedation in the pediatric population prior to undergoing multiple dental extractions under general anesthesia: a prospective, double-blind, randomized comparison. Anesth Prog. 2004;51(4):114.
Stephen R, Lingenfelter E, Broadwater-Hollifield C, Madsen T. Intranasal sufentanil provides adequate analgesia for emergency department patients with extremity injuries. J Opioid Manag. 2011;8(4):237-41.
Wisher D. Martindale: the complete drug reference. J Med Libr Assoc. 1999;100(1):75-6.
Steenblik J, Goodman M, Davis V, et al. Intranasal sufentanil for the treatment of acute pain in a winter resort clinic. Am J Emerg Med. 2012;30(9):1817-21.
Vercauteren M, Boeckx E, Hanegreefs G, Noorduin H, BUSSCHE G. Intranasal sufentanil for pre‐operative sedation. Anaesthesia. 1988;43(4):270-3.
Hostetler MA, Auinger P, Szilagyi PG. Parenteral analgesic and sedative use among ED patients in the United States: combined results from the National Hospital Ambulatory Medical Care Survey (NHAMCS) 1992-1997. Am J Emerg Med. 2002;20(2):83-7.
Henderson J, Brodsky D, Fisher D, Brett C, Hertzka R. Pre-induction of anesthesia in pediatric patients with nasally administered sufentanil. Anesthesiology. 1988;68(5):671-5.
Bates BA, Schutzman SA, Fleisher GR. A comparison of intranasal sufentanil and midazolam to intramuscular meperidine, promethazine, and chlorpromazine for conscious sedation in children. Ann Emerg Med. 1994;24(4):646-51.
Zedie N, Amory DW, Wagner BK, O'Hara DA. Comparison of intranasal midazolam and sufentanil premedication in pediatric outpatients. Clin Pharmacol Ther. 1996;59(3):341-8.
Helmers J, Noorduin H, Van Peer A, Van Leeuwen L, Zuurmond W. Comparison of intravenous and intranasal sufentanil absorption and sedation. Can J Anaesth. 1989;36(5):494-7.
Abrams R, Morrison J, Villasenor A, Hencmann D, Da Fonseca M, Mueller W. Safety and effectiveness of intranasal administration of sedative medications (ketamine, midazolam, or sufentanil) for urgent brief pediatric dental procedures. Anesth Prog. 1993;40(3):63-6.
Bounes V, Barthélémy R, Diez O, Charpentier S, Montastruc JL, Ducassé JL. Sufentanil is not superior to morphine for the treatment of acute traumatic pain in an emergency setting: a randomized, double-blind, out-of-hospital trial. Ann Emerg Med. 2010;56(5):509-16.
- Abstract Viewed: 519 times
- PDF (فارسی) Downloaded: 1022 times
- HTML (فارسی) Downloaded: 128 times
